Scott C. Kachlany
Oprichter bij Actinobac Biomed, Inc.
Actieve functies van Scott C. Kachlany
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Actinobac Biomed, Inc.
 Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Oprichter | 17-07-2009 | - |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2009 | - | |
| Directeur/Bestuurslid | 01-01-2009 | - | |
| Corporate Officer/Principal | - | - | |
Leukovet
 Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Directeur/Bestuurslid | - | - |
Loopbaan van Scott C. Kachlany
Eerdere bekende functies van Scott C. Kachlany
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | 01-01-2003 | - |
Opleiding van Scott C. Kachlany
| Cornell University | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
Leukovet
Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Health Technology |
- Beurs
- Insiders
- Scott C. Kachlany
- Ervaring
